Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody (GB221) for Injection

Condition:   HER-2-positive Advanced Breast Cancer Interventions:   Drug: GB221;   Drug: Placebo control Sponsor:   Genor Biopharma Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials